Market Overview
The treatment of aortic aneurysms is increasingly centered on minimizing procedural trauma while maintaining effective aneurysm exclusion and vessel support. Endovascular aneurysm repair (EVAR) addresses this requirement through minimally invasive stent graft placement, offering an alternative to conventional open surgery for abdominal and thoracic aortic aneurysms.
EVAR is particularly relevant where clinicians seek to reduce the invasiveness and recovery burden associated with open aneurysm repair. Through small groin incisions, a stent graft can be positioned within the affected section of the aorta to support the weakened vessel wall. This procedural approach, combined with ongoing development in graft design, imaging, fixation, and sealing technologies, is shaping the Endovascular Aneurysm Repair Market growth outlook.
For healthcare providers and device manufacturers, the commercial opportunity is closely tied to patient selection, procedural efficiency, technology adoption, reimbursement, and the ability of new devices to address increasingly complex aneurysm anatomies.
Market Scope
| Metric | Details |
| Market Size in 2025 | USD 3.20 Billion |
| Market Size by 2035 | USD 4.67 Billion |
| CAGR | 4.10% |
| Historic Years | 2023-2024 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Segments Covered | Product Type, Indication, Age, End-User, Region |
| Leading Region | North America |
| Fastest Growing Region | Asia Pacific |
To know More Insights: Sample Brochure
Key Takeaways
- USD 3.20 billion in 2025 establishes the current commercial scale of the Endovascular Aneurysm Repair Market, with the source projecting USD 4.30 billion by 2033.
- At a 4.1% CAGR, the market reaches an estimated USD 4.67 billion by 2035 when the source growth rate is extended beyond the reported forecast period.
- Adjunctive stent grafts represented the largest product segment in the source analysis, supported by their role in reducing postoperative stent graft limb occlusion risk.
- North America held the largest market share, supported by aneurysm prevalence, an aging population, established vascular care infrastructure, and demand for advanced minimally invasive interventions.
- Asia Pacific is identified as the fastest growing region, creating opportunities for manufacturers targeting expanding vascular intervention capacity.
- Polymer-based technologies are opening a product development pathway focused on customized aneurysm sealing, low-profile designs, and broader patient applicability.
- Reimbursement limitations and the higher cost of EVAR compared with open surgery remain important commercial considerations for providers, manufacturers, and procurement teams.
Why EVAR Matters in the Current Vascular Care Environment
Aortic aneurysms can produce serious complications, including rupture and other life threatening events. The source identifies abdominal pain, low blood pressure, loss of consciousness, and death among potential consequences associated with aortic aneurysms.
EVAR provides a minimally invasive treatment option that can reduce the surgical burden compared with traditional open repair. The ability to perform the procedure through smaller access points and support faster recovery has helped establish endovascular treatment as an important component of aneurysm management.
For healthcare systems, the purchasing decision extends beyond the initial device price. Procedure duration, hospitalization, recovery requirements, device performance, imaging requirements, and the ability to treat challenging anatomies can all influence the overall economic value of EVAR technologies.
Endovascular Aneurysm Repair Market Growth Drivers
Low Profile and Customized Graft Technologies Expand Treatment Possibilities
Innovation in endovascular treatment is an important growth catalyst. Polymer based technology has been proposed as an alternative approach for abdominal aortic aneurysm treatment, with platforms designed to create circumferential sealing around the aneurysm.
A polymer based platform can adapt its O-ring structure to the aortic wall, creating a customized seal that is intended to remain stable over time without influencing neck dilatation. The source also highlights the potential advantage of polymer channels instead of conventional metallic stent frames supporting the graft fabric.
For manufacturers, this technology direction addresses an important product development objective: increasing the number of patients who can potentially receive minimally invasive treatment while improving sealing characteristics.
Aging Population Supports Procedure Demand
The increasing prevalence of aneurysms among older adults supports demand for endovascular treatment. The source notes that aortic aneurysms are more common among men over 60 and identifies tobacco use, hypertension, and atherosclerosis as relevant risk factors.
The U.S. population aged 65 and above is also expected to increase substantially, creating a larger population potentially requiring vascular disease monitoring and treatment. This demographic development provides a long-term demand foundation for EVAR devices.
Advanced Imaging and Percutaneous Techniques Improve Procedural Efficiency
The source identifies increasing adoption of advanced imaging systems and fully percutaneous EVAR techniques as an important procedural development. These approaches can support greater procedural efficiency and reduced recovery time, reinforcing the broader movement toward minimally invasive vascular intervention.
For hospitals, investments in imaging capabilities and procedural infrastructure can therefore influence the adoption rate of newer EVAR systems.
Constraints Shaping the Endovascular Aneurysm Repair Market
Procedure Economics and Reimbursement Pressure
The cost of EVAR remains a consideration for healthcare providers because the procedure can be more expensive than open surgical repair. Insufficient reimbursement policies can therefore affect hospital purchasing decisions and the ability to expand access to advanced endovascular procedures.
Manufacturers need to demonstrate not only device performance but also economic value to hospitals and healthcare systems. Reduced recovery requirements and procedural efficiency can become important components of the purchasing case.
Device-Related Risks and Clinical Complexity
The source identifies stent movement as a concern alongside risks associated with aneurysm treatment and congestive heart failure. Device positioning, sealing, fixation, and long-term stability remain important considerations when selecting an EVAR platform.
These requirements create a competitive environment in which product reliability and anatomical adaptability are critical differentiators.
Endovascular Aneurysm Repair Market Segmentation
The Endovascular Aneurysm Repair Market is segmented by Product Type, by Indication, by Age, by End-User, and by Region - Share, Trends, and Forecast to 2035.
By Product Type
Product-level competition centers on stent graft technologies and adjunctive solutions. Adjunctive stent grafts held the largest share in the source analysis, reflecting their clinical role in supporting effective aneurysm repair and reducing complications such as limb occlusion.
By Indication
The market addresses aneurysm treatment applications involving the aorta, including abdominal and thoracic aneurysms. Product development increasingly focuses on complex anatomy and treatment situations where conventional repair approaches may present greater challenges.
By Age
Older patient populations represent a major demand base because the source identifies advanced age as an important factor associated with aortic aneurysm incidence. Demographic aging therefore remains relevant to long-term procedure volumes.
By End-User
Hospitals and vascular care facilities are central end users because EVAR requires specialized clinical teams, imaging capabilities, and procedural infrastructure. Procurement decisions increasingly involve assessment of device performance alongside procedural efficiency and overall treatment economics.
Regional Analysis
North America Maintains the Largest Market Position
North America held the largest market share in the source analysis. The region benefits from established healthcare infrastructure, specialist vascular services, and significant demand associated with aneurysm prevalence and population aging.
In the United States, the source reports an aortic aneurysm incidence of approximately 5 to 10 cases per 100,000 people and notes that aneurysms are more common among men over 60. Complications associated with aneurysms, including dissection and rupture, contribute to significant mortality.
The presence of established medical device manufacturers and advanced vascular intervention capabilities further supports North America's position. For suppliers, the region represents an important market for advanced graft systems, imaging-supported procedures, and minimally invasive vascular technologies.
Asia Pacific Offers the Fastest Growth Opportunity
Asia Pacific is identified as the fastest-growing region in the Endovascular Aneurysm Repair Market. Increasing healthcare capacity, improving access to advanced vascular procedures, and demographic changes are supporting the region's development.
For device manufacturers, the opportunity extends beyond product sales. Training, clinical support, distribution infrastructure, and relationships with hospitals can influence the pace at which advanced EVAR technologies are adopted.
Europe
Europe represents an established market for minimally invasive vascular intervention. Demand is supported by the clinical need to manage aneurysms among aging populations and by the availability of specialist vascular care.
The region also presents a procurement environment where device economics, clinical outcomes, regulatory requirements, and healthcare-system reimbursement can influence adoption.
Competitive Landscape and Company Strategies
The Endovascular Aneurysm Repair Market includes established medical device manufacturers and specialized vascular technology companies. Major companies identified in the source include Cardinal Health, Lombard Medical Limited, Endologix Inc., Terumo Corporation, MicroPort Scientific Corporation, JOTEC GmbH, W. L. Gore & Associates, Inc., Cook Group Incorporated, and Medtronic plc.
Competition is shaped by device reliability, anatomical coverage, sealing performance, fixation, deliverability, clinical support, and the ability to address complex aneurysm cases.
Medtronic
Medtronic maintains a broad medical device portfolio spanning multiple chronic disease areas and operates across approximately 140 countries, according to the source.
Its Heli-FX EndoAnchor System is designed to provide fixation and sealing between endovascular aortic grafts and the native artery. This product direction aligns with a key clinical requirement in EVAR: maintaining stable fixation and effective sealing following graft placement.
Product Differentiation is Shifting Toward Complex Anatomy
The competitive environment increasingly rewards technologies that can address difficult anatomical conditions while maintaining minimally invasive procedural benefits. Polymer-based sealing platforms, advanced imaging, percutaneous techniques, and specialized graft systems are therefore important areas of product development.
Recent Developments
In August 2026, Medtronic continued advancing its vascular portfolio with endovascular technologies designed to support minimally invasive treatment of aortic aneurysms and improve procedural outcomes.
- In July 2026, Cook Medical expanded its focus on endovascular aortic repair solutions, supporting physicians with minimally invasive technologies for complex aneurysm procedures.
- In June 2026, Gore Medical continued developing its portfolio of endovascular graft technologies for aortic aneurysm repair, with emphasis on device performance and procedural flexibility.
- In May 2026, Terumo Aortic strengthened its endovascular repair portfolio with technologies aimed at addressing complex aortic anatomies and supporting less invasive treatment approaches.
- In April 2026, Endologix continued advancing endovascular solutions for abdominal aortic aneurysm treatment, focusing on graft technologies and procedural options for vascular specialists.
- In March 2026, Cordis continued expanding its vascular intervention portfolio, supporting minimally invasive approaches for complex vascular disease and endovascular procedures.
Strategic Insights for Market Participants
The next phase of the EVAR market will be influenced by the ability to treat more complex aneurysm anatomies while maintaining the procedural advantages of minimally invasive intervention.
For manufacturers, product development should prioritize reliable sealing, fixation, lower profile delivery, and anatomical flexibility.
For healthcare providers, technology selection should balance clinical performance with procedural efficiency, infrastructure requirements, reimbursement, and total treatment economics.
For investors, product pipelines focused on advanced graft designs, polymer technologies, imaging integration, and complex aneurysm applications provide relevant areas for market assessment.
For suppliers, long-term opportunities extend into specialized components, procedural accessories, imaging systems, and supporting technologies required for advanced endovascular procedures.
Report Benefits
For Medical Device Manufacturers
The report helps manufacturers assess product segments, regional demand, competitive positioning, technology development, and market growth opportunities.
For Investors and Investment Firms
It provides market size, growth projections, competitive information, technology trends, and regional considerations relevant to investment evaluation.
For Hospitals and Procurement Teams
The analysis supports assessment of product direction, procedural technologies, supplier positioning, pricing considerations, and adoption factors.
For Emerging Companies
The report helps identify opportunities in advanced stent-graft systems, polymer-based technologies, imaging, minimally invasive procedures, and specialized vascular solutions.
For Strategy and Research Teams
The report provides a structured view of market dynamics, segmentation, geographic development, competitive activity, recent developments, and strategic considerations.
Target Audience
- Endovascular device manufacturers
- Medical device companies
- Hospitals and vascular care centers
- Healthcare procurement teams
- Vascular surgeons and specialists
- Medical technology investors
- Investment banks and financial institutions
- Suppliers and distributors
- Emerging medical device companies
- Healthcare strategy and research professionals
The global endovascular aneurysm repair market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
